undamentalytics Newsletter
Sign in

Collegium Pharmaceutical, Inc balance sheet

At the end of fiscal 2025, Collegium Pharmaceutical, Inc had total assets of $1.66bn, total liabilities of $1.36bn and shareholders' equity of $302m. It held $231m in cash against $238m of debt: net debt of $7.0m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents15311914717017418617423971231129
Receivables210787383106183180229211285
Inventory12810161747323641113
Total current assets159133238256278316420538482691608
Goodwill——————134134162146190
Total assets1621362913066446921,1741,1431,6641,6572,136
Accounts payable96126104394119
Deferred revenue (current)————————011
Total current liabilities2631189202239280434458510440590
Long-term debt4—1212100140141262237238239
Total debt4—1212100140141262237238239
Total liabilities27312002194584899799481,4351,3551,824
Shareholders' equity1351049287186203195195229302312
Net debt (negative = net cash)−149−119−135−159−75−46−33231677109
Shares outstanding29m33m33m34m35m34m34m———32m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: COLL vs CORTCOLL vs SUPNAXSM vs COLL

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Collegium Pharmaceutical, Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Collegium Pharmaceutical, Inc.